Detection of Viral Particels in Urticaria Patients
NCT03151902 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2025-09-15
Summary
Blood samples from urticaria patients will be analyzed for viral particles
Conditions
- Urticaria Chronic
Sponsors & Collaborators
-
HaEmek Medical Center, Israel
lead OTHER
Principal Investigators
-
Menachem Rottem · haemek medical center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-02
- Primary Completion
- 2024-09-30
- Completion
- 2024-09-30
Countries
- Israel
Study Locations
More Related Trials
-
Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria
NCT06819774 ·Status: RECRUITING ·Phase: PHASE3
-
Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria
NCT00525382 ·Status: COMPLETED ·Phase: PHASE3
-
This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines
NCT03926611 ·Status: COMPLETED ·Phase: PHASE2
-
Validation of an Allergic Rhinitis Control Test in Children
NCT03075917 ·Status: RECRUITING ·Phase: NA
-
Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria
NCT06072157 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutaneous Allergen Administration
NCT00719511 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HS-10561 Capsule in Healthy Chinese Adults and Patients With Chronic Spontaneous Urticaria.
NCT06864507 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201)
NCT01916967 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU)
NCT00598611 ·Status: COMPLETED ·Phase: PHASE3
-
Immunological Mechanisms of Allergy Immunotherapy
NCT01914029 ·Status: UNKNOWN
-
A Worldwide Antihistamine-Refractory Chronic Urticaria Patient Evaluation in Latin America and Canada (AWARE-LACan)
NCT02626221 ·Status: COMPLETED
-
Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis
NCT04324918 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating Symptom Control in in Allergic Rhinitis at Three Years After Starting Immunotherapy
NCT01777438 ·Status: COMPLETED
-
A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
NCT01012752 ·Status: UNKNOWN ·Phase: PHASE3
-
AWARE - Chronic Urticaria
NCT02435238 ·Status: COMPLETED
-
Multicenter Trial of Immunotherapy With House Dust Mite Allergoid
NCT00540631 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment Options for Chronic Urticaria
NCT06816784 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU).
NCT03137069 ·Status: COMPLETED ·Phase: PHASE2
-
Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria
NCT04853992 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147)
NCT00783354 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Efficacy and Safety of TLL-018 in CSU Participants
NCT06396026 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of Nasal Mucosal Permeability in Controls and House Dust Mite Allergic Rhinitis Patients
NCT02461797 ·Status: COMPLETED ·Phase: NA
-
An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
NCT06927999 ·Status: RECRUITING ·Phase: PHASE2
-
The Effect of Omalizumab on Allergic Rhinitis Symptoms: a Comparative Study
NCT06806826 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite Allergen
NCT01936818 ·Status: COMPLETED